Is transplantation of cryopreserved ovarian tissue from patients with advanced-stage breast cancer safe? A pilot study

被引：0
|
作者：
V. Luyckx
J. F. Durant
A. Camboni
S. Gilliaux
C. A. Amorim
A. Van Langendonckt
L. M. Irenge
J. L. Gala
J. Donnez
M. M. Dolmans
机构：
[1] Université Catholique de Louvain,Pôle de Recherche en Gynécologie, Institut de Recherche Expérimentale et Clinique
[2] Université Catholique de Louvain,Centre de Technologies Moléculaires Appliquées, Institut de Recherche Expérimentale et Clinique
[3] Belgian Armed Forces,Defense Laboratories Department, ACOS Ops&Trg
[4] Société de Recherche pour l’Infertilité (SRI),Infertility Research Unit
[5] Cliniques Universitaires Saint-Luc,Service de Gynécologie
[6] Université Catholique de Louvain,Department of Gynecology
[7] Cliniques Universitaires St Luc,undefined
来源：
Journal of Assisted Reproduction and Genetics | 2013年 / 30卷
关键词：
Fertility preservation; Breast cancer; Cryopreserved ovarian tissue; Ovarian tissue transplantation; Malignant contamination; Minimal residual disease; Xenografting; qPCR;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1289 / 1299
页数：10
相关论文
共 50 条
  • [31] Prevalence and Predictors of Complementary Therapy Use in Advanced-Stage Breast Cancer Patients
    Gross, Abigail M.
    Liu, Qin
    Bauer-Wu, Susan
    JOURNAL OF ONCOLOGY PRACTICE, 2007, 3 (06) : 292 - 295
  • [32] Centralization of care for patients with advanced-stage ovarian cancer: A cost-effectiveness analysis
    Bristow, Robert E.
    Santillan, Antonio
    Diaz-Montes, Teresa P.
    Gardner, Ginger J.
    Giuntoli, Robert L., II
    Meisner, Benjamin C.
    Frick, Kevin D.
    Armstrong, Deborah K.
    GYNECOLOGIC ONCOLOGY, 2007, 104 (03) : S2 - S2
  • [33] Centralization of care for patients with advanced-stage ovarian cancer - A cost-effectiveness analysis
    Bristow, Robert E.
    Santillan, Antonio
    Diaz-Montes, Teresa R.
    Gardner, Ginger I.
    Giuntoli, Robert L., II
    Meisner, Benjamin C.
    Frick, Kevin D.
    Armstrong, Deborah K.
    CANCER, 2007, 109 (08) : 1513 - 1522
  • [34] Spending On Targeted Therapies Reduced Mortality In Patients With Advanced-Stage Breast Cancer
    Li, Meng
    Goldman, Dana P.
    Chen, Alice J.
    HEALTH AFFAIRS, 2021, 40 (05) : 763 - 771
  • [35] Utilization of Primary Cytoreductive Surgery for Advanced-Stage Ovarian Cancer
    Bercow, Alexandra
    Stewart, Taylor
    Bregar, Amy J.
    Gockley, Allison
    Mazina, Varvara
    Rauh-Hain, J. Alejandro
    Melamed, Alexander
    JAMA NETWORK OPEN, 2024, 7 (10)
  • [36] The "Definitive" Trial of Surgical Cytoreduction in Advanced-Stage Ovarian Cancer
    Naik, Raj
    Spirtos, Nick
    Pomel, Christophe
    Bristow, Rob
    Chi, Dennis
    Vergote, Ignace
    Donovan, Jenny
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2013, 23 (04) : 588 - 591
  • [37] Latest research and treatment of advanced-stage epithelial ovarian cancer
    Robert L. Coleman
    Bradley J. Monk
    Anil K. Sood
    Thomas J. Herzog
    Nature Reviews Clinical Oncology, 2013, 10 : 211 - 224
  • [38] Safety and efficacy of neoadjuvant chemotherapy with bevacizumab in advanced-stage peritoneal/ ovarian cancer patients
    Kusunoki, Soshi
    Terao, Yasuhisa
    Hirayama, Takashi
    Fujino, Kazunari
    Ujihira, Takafumi
    Ota, Tsuyoshi
    Takeda, Satoru
    TAIWANESE JOURNAL OF OBSTETRICS & GYNECOLOGY, 2018, 57 (05): : 650 - 653
  • [39] Assessment of peritoneal cytology in advanced-stage ovarian cancer patients at interval debulking surgery
    Kato, K.
    Omatsu, K.
    Nomura, H.
    Matoda, M.
    Matsuura, M.
    Katsuda, T.
    Okamoto, S.
    Kondo, E.
    Kanao, H.
    Utsugi, K.
    Sugiyama, Y.
    Takeshima, N.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2016, 26 : 741 - 741
  • [40] Survival analysis of young patients with advanced-stage ovarian and primary peritoneal cancer.
    Chuang, L. T.
    Romano, S.
    Dottino, P. R.
    Rahaman, J.
    Lerner, D.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
12345